Literature DB >> 30649476

Novel Hemicraniectomy Technique for Malignant Middle Cerebral Artery Infarction: Technical Note.

Kristopher A Lyon1,2, Nitesh P Patel1,2, Yilu Zhang1,2, Jason H Huang1,2, Dongxia Feng1,2.   

Abstract

BACKGROUND AND IMPORTANCE: Decompressive hemicraniectomy (DH) is the mainstay of treatment for malignant middle cerebral artery infarction (MMI). Although this operation significantly reduces mortality and improves functional outcomes, the conventional technique involves a reverse question mark incision starting anterior to the tragus that can injure the scalp's major blood supply, the superficial temporal artery (STA), which increases the risk of postoperative complications. CLINICAL
PRESENTATION: We developed a modified DH technique to reduce surgical morbidity associated with injury to the STA, accommodate a large bone window for effective decompression, and improve operative speed. After performing hospital chart review, a total of 34 patients were found who underwent this DH technique for MMI. Of these, 22 patients had this performed for right-sided MMI and 12 patients had this performed for left-sided MMI.
CONCLUSION: In each case, our approach preserved the STA and thereby minimized the risk for ischemic necrosis of the scalp flap. Since our technique avoids dissection of the preauricular temporalis muscle, we believe operative times can be decreased while still accommodating a large bone window to allow for effective decompression of the infarcted brain parenchyma.
Copyright © 2019 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Decompression; Hemicraniectomy; Malignant middle cerebral artery infarction; Scalp necrosis; Superficial temporal artery; Technical note

Year:  2019        PMID: 30649476     DOI: 10.1093/ons/opy399

Source DB:  PubMed          Journal:  Oper Neurosurg (Hagerstown)        ISSN: 2332-4252            Impact factor:   2.703


  1 in total

1.  Tissue Healing in Hemicraniectomy.

Authors:  Ntenis Nerntengian; Tammam Abboud; Adam Stepniewski; Gunther Felmerer; Veit Rohde; Levent Tanrikulu
Journal:  Cureus       Date:  2022-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.